vutrisiran

Spain

Drugs containing this active substance

  • AMVUTTRA 25 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

    It is used to treat ATTR amyloidosis, a disease that can be hereditary or caused by aging, which occurs when the transthyretin (TTR) protein forms amyloid deposits in the body.

    Form: solution for injection in a pre-filled syringe

    Active substance Dosage
    vutrisiran 25 mg

    ATC: N07X N07XX N07XX18

    Manufacturer: Alnylam Netherlands B.V.